September 12, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Immunoadsorption, Off-label DMTs, Resistance Training, COVID-19 Vaccines Immunoadsorption Better Than 2nd Round of Steroids for MS Relapse This is an interesting study, particularly because of the physical problems that can be caused by significant steroid use over the years. Of course, immunoadsorption is essentially a blood transfusion; it involves collecting a patientās blood; separating out its…
August 29, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Epstein-Barr, Aqua Exercise, Diagnosing SPMS, Myelin Repair Epstein-Barr Virus and MS Risk: New Link to Mono Found in Study Add this study to the mounting evidence that there’s some type of association between the Epstein-Barr virus (EBV) ā the virus associated with mononucleosis ā and multiple sclerosis. I’ve never had mono, but several people with…
August 22, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: PBA, Pregnancy, Interferon-beta, Pediatric MS Test Early Detection of Pseudobulbar Affect May Help Ease MS Symptom I often see posts on social media from people with MS asking if crying for no reason is an MS symptom, because it happens to them. I didn’t know that apparently, it is. Laughing, too. This report says…
August 15, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: COVID-19 Vaccines, Robot Training, Bladder Treatment, Tysabri Anti-CD20 Therapies Help Mount T-cell Response to COVID-19 Vaccines Since the start of the COVID-19 pandemic, there have been concerns that anti-CD20 therapies, such as Ocrevus (ocrelizumab), may interfere with the ability of a person with MS to fight a COVID-19 infection. But this report says that even if…
August 8, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Stem Cell Transplant, Tysabri, Exercise, Zinc Stem Cell Transplant Found to Reduce MS Relapses, Ease Disability This is excellent news for those of us who would like to see stem cell transplant for MS become more available and affordable. These researchers analyzed 50 studies covering a total of 4,831 people with MS, ages 26 to…
August 1, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Vitamin D, Brain Health, Digoxin, Natalizumab No Link Between MS Severity, Vitamin D-related Mutations: Study Several studies over the years have indicated that there could be a link between a person’s vitamin D level and the risk of multiple sclerosis (MS). This study is slightly different. Researchers looked at whether genetic variations related to vitamin…
July 25, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Intermittent Fasting, Roe v. Wade, IRLs Intermittent Fasting in MS Leads to Immune Cell, Metabolic Changes Although the National MS Society will tell you there is no such thing as an “MS diet,” many people follow various diets that seem to help them. One that’s been around for several years is intermittent fasting. In…
July 18, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: ATA188 in Progressive MS, Early Symptoms, Yoga, Rituximab EMBOLD Study of ATA188 in Progressive MS Is Given Go-ahead Is this another small step toward an MS cure? AT188 is an experimental therapy designed to kill cells infected with the Epstein-Barr virus (EBV). As you probably know, researchers have found a lot of evidence that EBV is connected…
February 21, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Brain Atrophy, CD25, Neurodynamic Therapy, Anxiety Fatigue Severity in MS Predicted by Shrinkage of Certain Brain Regions For several years, I’ve been a believer, along with many neurologists, in the theory that it’s best to treat MS as quickly and effectively as possible. Though directed at only fatigue indicators, this research looking at brain atrophy…
February 7, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Predicting Disease Progression, Temelimab, Trigeminal Neuralgia Combined Data May Predict Personās Risk of Advancing From CIS to MS Clinically isolated syndrome is sometimes called “early MS.” It’s the diagnosis used when someone’s symptoms don’t quite look like MS, but it does appear that MS is lurking. It may take years for an actual…
June 5, 2017 Columns by Ed Tobias MS News That Caught My Eye: An Acne Drug, a High-Cost Gel, Good News About Lemtrada, and Getting Off MS Drugs In case you missedĀ them, here are some news stories that appeared in MS News Today that caught my eye over the past week. Acne Therapy Reduces Rate of Multiple Sclerosis Progression, Canadian Study Reports At first glance, the headlines about this drug announced what seemed to be…